| Literature DB >> 1594262 |
Franco De Conno1, Carla Ripamonti, Mauro Bianchi, Vittorio Ventafridda, Alberto E Panerai.
Abstract
We determined morphine plasma concentrations in 6 cancer patients before and with administration of diclofenac for 5 days. The non-steroidal anti-inflammatory drug does not modify morphine bioavailability. This observation suggests that diclofenac can be used in association with morphine during cancer pain treatment, without increasing the risk of overdosage or side effects of the opiate.Entities:
Mesh：
Substances：
Year: 1992 PMID： 1594262 DOI： 10.1016/0304-3959(92)90091-O
Source DB: PubMed Journal: Pain ISSN： 0304-3959 Impact factor: 6.961